Mode
Text Size
Log in / Sign up

C3-derived skeletal muscle index shows strong correlation with L3 index in head and neck cancerC3 Muscle Index Shows Strong Link to L3 Muscle Levels

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that C3-derived muscle indices correlate strongly with L3 indices as a potential radiation-sparing sarcopenia assessment.

This meta-analysis of 2017 patients evaluates the correlation between CT-derived skeletal muscle indices at the C3 and L3 levels in patients with head and neck cancer. The study aims to determine if C3-derived measurements can serve as a surrogate for L3 measurements, which are traditionally used to assess sarcopenia.

The analysis found a strong positive correlation of 0.79 (95% CI: 0.73 to 0.84) between the C3 and L3 muscle indices. Sex-specific analyses revealed even stronger correlations in men (0.92) and women (0.94). Additionally, BMI-modified agreement showed that correlation increased with higher BMI, rising from 0.70 at BMI 23 to 0.90 at BMI 27.

The authors note that prospective multicenter studies are required to standardize protocols and validate the clinical utility of these measurements. While C3-derived quantification may offer a radiation-sparing method for sarcopenia assessment, the results indicate a correlation rather than a direct causal link. Clinical utility remains subject to further validation in prospective settings.

How this fits prior evidence

This meta-analysis addresses a gap in identifying accessible methods for sarcopenia assessment in head and neck cancer. It builds upon prior evidence showing that sarcopenia is associated with tripled dysphagia odds across cancers and that malnutrition and sarcopenia are associated with higher toxicity and poorer outcomes in head and neck cancer. By identifying a strong correlation between C3 and L3 indices, this study explores a potential radiation-sparing surrogate for identifying patients at risk for these complications.

Researchers analyzed data from 2,017 adult patients with head and neck cancer to compare two ways of measuring muscle mass. They looked at the correlation between muscle measurements taken at the C3 level of the neck and the L3 level of the lower back. The study found a strong correlation between these two locations, which suggests that neck scans might accurately reflect body muscle levels.

The study also looked at how sex and body mass index (BMI) affected these results. Both men and women showed strong correlations between the two measurement sites. Additionally, the agreement between the two sites increased as BMI increased. This is important because patients with head and neck cancer often undergo radiation to the neck area.

Because the evidence comes from a meta-analysis of existing data, more large-scale studies are needed to confirm if this method can be used in daily practice. While the results are promising for finding a simpler way to check for muscle loss, it is currently considered a surrogate measure. Patients should talk to their doctors about how these imaging techniques might apply to their specific treatment plan.

What this means for you:
Neck scans may provide a reliable way to measure muscle mass in head and neck cancer patients.

Common questions

What is the benefit of using C3 scans instead of L3 scans?

Using a C3 measurement might be more convenient for patients with head and neck cancer. Because it focuses on the neck area, it could potentially be a radiation-sparing way to check for muscle loss (sarcopenia) compared to imaging the lower back at the L3 level.

How accurate is the link between neck and back muscle measurements?

The study found a strong correlation of 0.79 between the C3 and L3 muscle indices. This correlation was even stronger in both men and women, with scores of 0.92 and 0.94 respectively, suggesting the two areas are closely linked in these patients.

Does a patient's weight affect the accuracy of these measurements?

The study found that the agreement between the two measurement sites increased as BMI went up. Specifically, the correlation rose from 0.70 at a BMI of 23 to 0.90 at a BMI of 27, showing that higher body mass may improve the consistency between the two sites.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Sarcopenia, characterized by loss of skeletal muscle mass, predicts adverse outcomes in head and neck cancer but is underrecognized due to reliance on third lumbar-level (L3) CT, which is not routinely performed. The third cervical vertebra (C3) is consistently imaged in head and neck cancer, offering a potential replacement for L3 sarcopenia assessment. METHODS: We conducted a systematic review and meta-analysis of studies reporting concurrent CT-derived skeletal muscle index at C3 and L3 in adult head and neck cancer patients. PubMed, Embase, Web of Science, and Cochrane Library were searched through August 30, 2025, without language restrictions. Pooled Pearson correlation coefficients between C3 and L3 measurements were calculated using a random-effects model. Subgroup analyses stratified by sex and BMI, as well as meta-regression, assessed potential modifiers. RESULTS: Fourteen studies encompassing 2017 head and neck cancer patients met the inclusion criteria. The overall pooled correlation between C3 and L3 muscle indices was 0.79 (95% CI: 0.73 to 0.84; I = 90.3%). Sex-specific correlations were stronger (men: 0.92; women: 0.94), and BMI positively modified agreement (correlation increased from 0.70 at BMI 23 to 0.90 at BMI 27). CONCLUSION: C3-derived muscle quantification demonstrates a strong correlation with L3 assessment, particularly when applying sex- and BMI-informed thresholds. Routine cervical imaging may enable accessible, radiation-sparing sarcopenia evaluation in head and neck cancer. Prospective multicenter studies are needed to standardize protocols and validate clinical utility.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.